Guido M. Sclabas

Learn More
PURPOSE Pancreatic adenocarcinoma is currently the fourth leading cause of cancer death in the United States, and most pancreatic cancers develop locally advanced disease or metastasis at the time of diagnosis. The mechanisms by which it invades and metastasizes are not known. EXPERIMENTAL DESIGN To identify the genes involved in pancreatic cancer(More)
Molecular Cancer has been launched for one year now. Here, we describe achievements of the past year and future goals of the journal. Editorial It is a time of change [1]. There is no doubt that the uncen-sored exchange of scientific results hastens progress and will be the gold standard for any journal [2–7]. BioMed Central, the publisher of Molecular(More)
Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its publisher BioMed Central. Editorial There is no question that immediate and unrestricted access to information stimulates scientific communication. The Freedom of Information(More)
"BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime." The data published in this article [1] and in a subsequent article in Molecular Cancer [2] were generated by myself, the corresponding author, with collaborators in Germany. The data were originally part of a manuscript on which(More)
  • 1